The Texas House of Representatives passed a bill advocating for the state to start conducting studies on therapeutic potential psychedelics including psilocybin and MDMA. The house voted 134:12 in favor of the bill sponsored by Rep. Alex Dominguez.
The bill was passed on May 6, earlier in the day, the bill had passed for a second reading. Following this, the bill is now headed to the United States Senate.
“We lose about 6,000 veterans every year and since 2001, we have lost 114,000 of our veterans to PTSD and suicide,” said Dominguez shortly before the second reading of the bill.
According to Dominguez, the bill will do something that is greatly needed and that is taking a new shape on how lawmakers can do to save lives of servicemen and women that have dedicated their lives to serve the country.
The bill will require Texas State to initiate studies to find out the risks and benefits of psilocybin, ketamine and MDMA in collaboration with Baylor College of Medicine and a military-focused medical center.
Additionally, the bill also seeks for a clinical trial into psilocybin for patients suffering from post-traumatic stress disorder(PDST).
